Clinical Trial

The K-Map Study, Global Prevalence of KC

Recruiting
View on ClinicalTrials.gov →
Summary
Keratoconus is a ocular disease classified under ectatic diseases which often results in bilateral and asymmetrical corneal distortion. It usually affects patients at young age and can cause severe visual loss. The overall goal of this study is to assess the prevalence of keratoconus (KC) in children and adolescents in various regions of the world based on modern tomographic imaging methods, and to verify whether the occurrence rates reported from literature should be corrected. Our hypothesis is that the prevalence of the disease is much higher than that traditionally reported. At each site, corneal tomography examinations (Pentacam) will be performed bilaterally in children and adolescents, who are not ill or with any ophthalmological symptom. The population to be studied will be composed of children and adolescents on medical visits for non-ophthalmologic reasons, aged between 6 and 20 years. Multiple cities, from different continents (North America, South America, Asia and Europe) will participate.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2017-04-10; most recent amendment 2025-08-06.
Trial Details
NCT Number NCT03115710
Lead Sponsor University Hospital, Geneva
Collaborators: ELZA Institute
Conditions Keratoconus
Enrollment 20,000 participants
Start Date 2015-12-28
Primary Completion 2030-02-01 (estimated)
Study Completion 2030-02-01 (estimated)
Updated on ClinicalTrials.gov 2025-08-11